About this video
This video is the roughly 1 hour 20 minute recording of the live broadcast of Acıbadem Kayseri Hospital on 15 April 2022, in which Prof. Dr. Ayşe Öner gave a presentation on "Stem Cell Therapy in Eye Diseases" and answered viewers' questions. The talk is in Turkish.
What does the video cover?
- 1:24 Prof. Dr. Ayşe Öner explains that she has worked on stem cell applications in eye diseases for about 10 years, in cooperation with the Turkish Ministry of Health.
- 2:49 What are stem cells? Embryonic and adult stem cells; embryonic stem cells are not permitted in Turkey, while adult (mesenchymal) stem cells are obtained from fat tissue, bone marrow and the umbilical cord; applications require approval from the Ministry of Health.
- 5:46 How do stem cells work? The mesenchymal stem cells used do not bring dead cells back; they act as a supportive treatment, helping diseased cells function through the growth factors they release.
- 7:13 Why is the eye, a small organ needing few cells, well suited to stem cell applications?
- 8:14 Viewer questions: optic atrophy, light sensitivity, night blindness and dry macular degeneration; disease stage and level of vision matter more than age; the effect can decrease over time and the application can be repeated.
- 16:46 Methods of application: injections into the eye and under the retina, and the suprachoroidal method, which does not enter the eye.
- 18:37 Disease groups treated: retinitis pigmentosa, severe inherited retinal diseases starting in childhood, dry and juvenile inherited macular diseases, and some optic neuropathies.
- 20:11 How families can notice night blindness in children; regular eye examinations for children; the role of electrophysiological tests and OCT in diagnosis.
- 25:36 Applications are carried out with Ministry approval and reported regularly; treatment in children and better response at an early stage.
- 26:39 What does the success rate mean? Not every patient responds, and miraculous expectations should be avoided.
- 29:15 Ongoing laboratory research and teamwork.
- 30:44 Viewer questions: eye transplantation, insurance coverage, lazy eye (amblyopia), differences in response between disease groups, and publications.
- 40:14 Viewer questions: other retinal diseases, safety of the application, cell production and the day of the procedure.
- 54:22 Lifestyle advice: harm of smoking, sun protection, diet and supplements, follow-up after the application.
- 1:17:16 Closing: stem cell application is not a cure but a supportive treatment that gains time.
The video was published by Acıbadem Healthcare Group in 2022.
This content is for information only; please consult your physician for diagnosis and treatment.